These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 23679074

  • 1. Late HBsAg seroreversion of mutated hepatitis B virus after bone marrow transplantation.
    Schubert A, Michel D, Mertens T.
    BMC Infect Dis; 2013 May 16; 13():223. PubMed ID: 23679074
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Risk of hepatitis B surface antigen seroreversion after allogeneic hematopoietic SCT.
    Viganò M, Vener C, Lampertico P, Annaloro C, Pichoud C, Zoulim F, Facchetti F, Poli F, Scalamogna M, Deliliers GL, Colombo M.
    Bone Marrow Transplant; 2011 Jan 16; 46(1):125-31. PubMed ID: 20383209
    [Abstract] [Full Text] [Related]

  • 4. Fulminant hepatitis after allogenic bone marrow transplantation caused by reactivation of hepatitis B virus with gene mutations in the core promotor region.
    Kitano K, Kobayashi H, Hanamura M, Furuta K, Ueno M, Rokuhara A, Tanaka E, Umemura T, Kiyosawa K.
    Eur J Haematol; 2006 Sep 16; 77(3):255-8. PubMed ID: 16923112
    [Abstract] [Full Text] [Related]

  • 5. Management of Hepatitis B Virus in Allogeneic Hematopoietic Stem Cell Transplantation.
    Wu Y, Huang H, Luo Y.
    Front Immunol; 2020 Sep 16; 11():610500. PubMed ID: 33613534
    [Abstract] [Full Text] [Related]

  • 6. Prophylactic antiviral therapy in allogeneic hematopoietic stem cell transplantation in hepatitis B virus patients.
    Liao YP, Jiang JL, Zou WY, Xu DR, Li J.
    World J Gastroenterol; 2015 Apr 14; 21(14):4284-92. PubMed ID: 25892880
    [Abstract] [Full Text] [Related]

  • 7. Determining Whether Prophylactic Antiviral Treatment Is Necessary in HBsAg-Negative/HBcAb-Positive Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation.
    Zhang A, Wu Y, Tan Y, Shi J, Zhao Y, Hu Y, Yu J, Zheng W, Lai X, Zhang M, Zhu Y, Ye Y, Huang Y, Fu S, Huang H, Luo Y.
    Biol Blood Marrow Transplant; 2020 May 14; 26(5):956-964. PubMed ID: 31962163
    [Abstract] [Full Text] [Related]

  • 8. Reactivation of resolved hepatitis B virus infection combined with nephrotic syndrome in a patient after allogeneic haematopoietic stem cell transplantation.
    Zhang JW, Zhang XZ, Sun YL, Long B, Wang XZ, Li XD.
    BMC Infect Dis; 2019 Jan 16; 19(1):57. PubMed ID: 30651070
    [Abstract] [Full Text] [Related]

  • 9. Reactivation of hepatitis B virus infection following rituximab treatment in HBsAg-negative, HBcAb-positive rheumatoid arthritis patients: A long-term, real-world observation.
    Chen YM, Chen HH, Huang WN, Chen YH, Hsieh TY, Yang SS, Lan JL, Chen DY.
    Int J Rheum Dis; 2019 Jun 16; 22(6):1145-1151. PubMed ID: 31117160
    [Abstract] [Full Text] [Related]

  • 10. Reactivation of hepatitis B virus with mutated hepatitis B surface antigen in a liver transplant recipient receiving a graft from an antibody to hepatitis B surface antigen- and antibody to hepatitis B core antigen-positive donor.
    Blaich A, Manz M, Dumoulin A, Schüttler CG, Hirsch HH, Gerlich WH, Frei R.
    Transfusion; 2012 Sep 16; 52(9):1999-2006. PubMed ID: 22313146
    [Abstract] [Full Text] [Related]

  • 11. HBV Reactivation in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Narrative Review.
    Gentile G, Antonelli G.
    Viruses; 2019 Nov 10; 11(11):. PubMed ID: 31717647
    [Abstract] [Full Text] [Related]

  • 12. Hepatitis B reactivation characterized by HBsAg negativity and anti-HbsAg antibodies persistence in haematopoietic stem cell transplanted patient after lamivudine withdrawal.
    Cerva C, Maffongelli G, Svicher V, Salpini R, Colagrossi L, Battisti A, Mariotti B, Cerretti R, Cudillo L, Sarmati L.
    BMC Infect Dis; 2017 Aug 15; 17(1):566. PubMed ID: 28806922
    [Abstract] [Full Text] [Related]

  • 13. HBV reactivation risk factors in patients with chronic HBV infection with low replicative state and resolved HBV infection undergoing hematopoietic stem cell transplantation in Korea.
    Jun CH, Kim BS, Oak CY, Lee DH, Cho E, Cho SB, Choi SK, Park CH, Joo YE, Lee JJ, Kim HJ.
    Hepatol Int; 2017 Jan 15; 11(1):87-95. PubMed ID: 27351765
    [Abstract] [Full Text] [Related]

  • 14. Adefovir is effective to promote development of immunity to donor origin hepatitis B virus in an allogeneic transplant recipient: a case report.
    Yaşar DG, Suyanı E, Özenirler S, Sucak GT.
    Transplant Proc; 2013 Mar 15; 45(2):833-4. PubMed ID: 23498831
    [Abstract] [Full Text] [Related]

  • 15. Reactivation of hepatitis B virus in hematopoietic stem cell transplant recipients in Japan: efficacy of nucleos(t)ide analogues for prevention and treatment.
    Nakamoto S, Kanda T, Nakaseko C, Sakaida E, Ohwada C, Takeuchi M, Takeda Y, Mimura N, Iseki T, Wu S, Arai M, Imazeki F, Saito K, Shirasawa H, Yokosuka O.
    Int J Mol Sci; 2014 Nov 21; 15(11):21455-67. PubMed ID: 25421241
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Long-term surveillance of haematopoietic stem cell recipients with resolved hepatitis B: high risk of viral reactivation even in a recipient with a vaccinated donor.
    Knöll A, Boehm S, Hahn J, Holler E, Jilg W.
    J Viral Hepat; 2007 Jul 21; 14(7):478-83. PubMed ID: 17576389
    [Abstract] [Full Text] [Related]

  • 18. Hepatitis B virus reactivation and efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantation.
    Giaccone L, Festuccia M, Marengo A, Resta I, Sorasio R, Pittaluga F, Fiore F, Boccadoro M, Rizzetto M, Bruno B, Marzano A.
    Biol Blood Marrow Transplant; 2010 Jun 21; 16(6):809-17. PubMed ID: 20060484
    [Abstract] [Full Text] [Related]

  • 19. Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg-negative and anti-HBc antibodies-positive patients undergoing chemotherapy and/or autologous stem cell transplantation for cancer.
    Borentain P, Colson P, Coso D, Bories E, Charbonnier A, Stoppa AM, Auran T, Loundou A, Motte A, Ressiot E, Norguet E, Chabannon C, Bouabdallah R, Tamalet C, Gérolami R.
    J Viral Hepat; 2010 Nov 21; 17(11):807-15. PubMed ID: 20002298
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.